Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An
anticancer drug .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word eribulin.
Examples
-
Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) today announced preliminary results from a recently completed Phase III study with E7389 (generic name: eribulin mesylate, "eribulin"), discovered and developed by the Company, in patients with locally advanced or metastatic breast cancer.
Presseportal 2009
-
In the past year, two new drugs have been approved -- Halaven (eribulin) and Xgeva (denosumab) -- and others are in clinical trials.
Dr. Elaine Schattner: Seeing the Metastatic Side of Breast Cancer Dr. Elaine Schattner 2011
-
In the past year, two new drugs have been approved -- Halaven (eribulin) and Xgeva (denosumab) -- and others are in clinical trials.
Dr. Elaine Schattner: Seeing the Metastatic Side of Breast Cancer Dr. Elaine Schattner 2011
-
In the past year, two new drugs have been approved -- Halaven (eribulin) and Xgeva (denosumab) -- and others are in clinical trials.
Dr. Elaine Schattner: Seeing the Metastatic Side of Breast Cancer Dr. Elaine Schattner 2011
-
In the past year, two new drugs have been approved -- Halaven (eribulin) and Xgeva (denosumab) -- and others are in clinical trials.
Dr. Elaine Schattner: Seeing the Metastatic Side of Breast Cancer Dr. Elaine Schattner 2011
-
In the past year, two new drugs have been approved -- Halaven (eribulin) and Xgeva (denosumab) -- and others are in clinical trials.
Dr. Elaine Schattner: Seeing the Metastatic Side of Breast Cancer Dr. Elaine Schattner 2011
-
In the past year, two new drugs have been approved -- Halaven (eribulin) and Xgeva (denosumab) -- and others are in clinical trials.
Dr. Elaine Schattner: Seeing the Metastatic Side of Breast Cancer Dr. Elaine Schattner 2011
-
Eisai Inc. 's eribulin, derived from a sea sponge, improved survival for women with advanced breast cancer and could fill some key treatment gaps.
-
Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastatic breast cancer
THE MEDICAL NEWS Editors 2010
-
Eisai Inc. 's eribulin, derived from a sea sponge, improved survival for women with advanced breast cancer and could fill some key treatment gaps.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.